Mark Livingston Biography and Net Worth

CEO of Progyny

Mark is a seasoned finance executive with demonstrated success transitioning entrepreneurial businesses to high growth corporate entities. Prior to joining Progyny, Mark was the Integration Management Officer at Scripps Networks driving its merger with Discovery Communications. He also served as SVP Finance and CFO International at Scripps, and in senior finance roles at Emerson Reid, Emdeon and Hess.

What is Mark S. Livingston's net worth?: The estimated net worth of Mark S. Livingston is at least $1.66 million as of April 1st, 2024. Mr. Livingston owns 50,119 shares of Progyny stock worth more than $1,656,934 as of April 22nd. This net worth evaluation does not reflect any other assets that Mr. Livingston may own. Additionally, Mr. Livingston receives an annual salary of $693,870.00 as CEO at Progyny. Learn More about Mark S. Livingston's net worth.
How old is Mark S. Livingston?: Mr. Livingston is currently 58 years old. There are 4 older executives and no younger executives at Progyny. The oldest executive at Progyny is Mr. David J. Schlanger, Executive Chairman, who is 65 years old. Learn More on Mark S. Livingston's age.
What is Mark S. Livingston's salary?: As the CEO of Progyny, Inc., Mr. Livingston earns $693,870.00 per year. There are 2 executives that earn more than Mr. Livingston. The highest earning executive at Progyny is Mr. Peter Anevski, CEO & Director, who commands a salary of $1,010,000.00 per year. Learn More on Mark S. Livingston's salary.
How do I contact Mark S. Livingston?: The corporate mailing address for Mr. Livingston and other Progyny executives is 1359 BROADWAY, NEW YORK NY, 10018. Progyny can also be reached via phone at 212-888-3124 and via email at [email protected]. Learn More on Mark S. Livingston's contact information.
Has Mark S. Livingston been buying or selling shares of Progyny?: In the last ninety days, Mark S. Livingston has sold $420,027.30 of Progyny stock. Most recently, Mark S. Livingston sold 11,165 shares of the business's stock in a transaction on Monday, April 1st. The shares were sold at an average price of $37.62, for a transaction totalling $420,027.30. Following the completion of the sale, the chief financial officer now directly owns 50,119 shares of the company's stock, valued at $1,885,476.78. Learn More on Mark S. Livingston's trading history.
Who are Progyny's active insiders?: Progyny's insider roster includes Peter Anevski (COO), Jennifer Bealer (EVP), Kevin Gordon (Director), Lisa Greenbaum (EVP), Mark Livingston (CEO), Norman Payson (Director), David Schlanger (CEO), Cheryl Scott (Director), and Michael Sturmer (President). Learn More on Progyny's active insiders.
Are insiders buying or selling shares of Progyny?: In the last twelve months, insiders at the sold shares 38 times. They sold a total of 3,784,012 shares worth more than $152,303,570.89. The most recent insider tranaction occured on April, 1st when Chairman David J Schlanger sold 1,000 shares worth more than $37,520.00. Insiders at Progyny own 12.3% of the company. Learn More about insider trades at Progyny.
Information on this page was last updated on 4/1/2024.

Mark S. Livingston Insider Trading History at Progyny

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/1/2024	Sell	11,165	$37.62	$420,027.30	50,119
1/2/2024	Sell	12,368	$36.59	$452,545.12	46,871
12/1/2023	Sell	25,087	$34.62	$868,511.94	49,983
11/29/2022	Sell	14,801	$36.70	$543,196.70	63,994
11/8/2021	Sell	15,858	$65.61	$1,040,443.38
6/21/2021	Sell	23,221	$62.40	$1,448,990.40	19,935
12/2/2020	Sell	10,662	$36.54	$389,589.48	34,126

Mark S. Livingston Buying and Selling Activity at Progyny

Progyny Company Overview

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Today's Range

Now: $33.06

$32.66

$33.36

50 Day Range

MA: $36.51

$31.88

$41.38

2 Week Range

Now: $33.06

$29.44

$44.95

Volume

663,390 shs

Average Volume

788,947 shs

Market Capitalization

$3.18 billion

P/E Ratio

53.32

Dividend Yield

N/A

Beta

1.48

Healthcare Takes A Big Step Forward With The Help Of AI

From The Bull Report | Ad

The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.

Click here to see why this small company is trusted by the Mayo Clinic

Mark Livingston Biography and Net Worth

What is Mark S. Livingston's net worth?

How old is Mark S. Livingston?

What is Mark S. Livingston's salary?

How do I contact Mark S. Livingston?

Has Mark S. Livingston been buying or selling shares of Progyny?

Who are Progyny's active insiders?

Are insiders buying or selling shares of Progyny?